Here is the latest stock price and chart of Dr. Reddys. For more details, see the Dr. Reddys company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Live BSE Quotes | Dec 6, 2019 (Close) | ||
---|---|---|---|
Price (Rs)2,891.95 | Open (Rs) 2,925.00 | High (Rs) 2,947.00 | Low (Rs) 2,874.30 |
% Change0.76 | Volume 27,353 | Value (Rs) 79,790,722 | 52-Week H/L 2,990.00 / 2,065.30 |
Live NSE Quotes | Dec 6, 2019 (Close) | ||
---|---|---|---|
Price (Rs)2,890.80 | Open (Rs) 2,887.70 | High (Rs) 2,949.00 | Low (Rs) 2,871.65 |
% Change0.67 | Volume 988,519 | Value (Rs) 2,886,137,558 | 52-Week H/L 2,991.95 / 1,872.95 |
Valuation | |||
---|---|---|---|
EPS (Rs)* 162.11 | P/E Ratio (x) 17.84 | Market Cap (Rs m) 479,225.03 | P/BV (x) 3.42 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
Listen In: Our Investor Hour Podcast Connects You with the World's Most Successful Investors
S&P BSE SENSEX ![]() |
||||||
PERIOD |
DR. REDDYS LAB last traded price was up 0.8% to Rs 2,892.0 on the BSE. On the NSE, DR. REDDYS LAB last traded price was up 0.7% to Rs 2,890.8. The total volume of shares traded was 1.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.9%. And the benchmark S&P BSE SENSEX was at 40,445.2 (down 0.8%).
Over the last 30 days, the DR. REDDYS LAB share price is up 1.0%. And over the last one year, DR. REDDYS LAB share price is up 9.5%.
| |
In addition to the usual stock market updates of the week, I talk about how RBI's monetary policy decision and slowing economy impacts you and your portfolio of stocks.
For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.
For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.
US business was hit by pricing pressure although there was growth sequentially led by new product launches.
Should you subscribe to the IPO of Aster DM Healthcare Ltd?
More Views on NewsA single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.
This one trade had my subscribers laughing all the way to the bank.
What we can learn from one of the greatest traders to have ever lived.
Should you invest in growth stocks or value stocks to make strong returns in this market?
The two trends that are playing out as Sensex touches new record high.
More